Repaglinide pharmacokinetics are characterised by a mean absolute bioavailability of 63% (CV 11%), low volume of distribution, 30 L (consistent with distribution into intracellular fluid), and rapid elimination from the blood.
Repagliniidi farmakokineetikale on iseloomulik keskmine täielik biosaadavus 63% (CV 11%), väike jaotumismaht 30 l (mis vastab levikule intratsellulaarsesse koevedelikku) ning kiire elimineerumine verest.